Tag: Pharmaceutical Investing

Home » Pharmaceutical Investing
"Wrap-around Care" Model Helps Address Gaps in Mental Healthcare
Post

“Wrap-around Care” Model Helps Address Gaps in Mental Healthcare

With over 1.3 million Canadians currently struggling with trauma and post-traumatic stress disorder (PTSD), Pure Life Healthcare Management is working to offer a wrap-around care model for better healing, according to CEO Doug Page. The model allows individuals to walk in and have a single health provider deliver a wide spectrum of support for healing....

Pure Life Healthcare Management Announces Acquisition of Revolution Medical Cannabis Clinic
Post

Pure Life Healthcare Management Announces Acquisition of Revolution Medical Cannabis Clinic

Hotbed of healthcare innovation So what is it about Europe that makes it so well-suited for the development and distribution of new healthcare technologies? A different way of thinking As noted by Forbes, German business culture demands continuous improvement, eschewing static design and safety in favor of disruptive ideas. German entrepreneurs also tend to make...

Pure Life Healthcare Management: Full-spectrum Strategy for PTSD Care
Post

Pure Life Healthcare Management: Full-spectrum Strategy for PTSD Care

Hotbed of healthcare innovation So what is it about Europe that makes it so well-suited for the development and distribution of new healthcare technologies? A different way of thinking As noted by Forbes, German business culture demands continuous improvement, eschewing static design and safety in favor of disruptive ideas. German entrepreneurs also tend to make...

Pure Life: Let's Make a Change
Post

Pure Life Healthcare Management Investor Overview

Overview Pure Life Healthcare Management aims to change the healthcare landscape for people suffering from post-traumatic stress disorder (PTSD) by providing integrated, wrap-around care that responds to the unique needs of this significantly underserved population. Over 1.3 million people in Canada live with some form of PTSD or trauma. Many are veterans, first responders, healthcare...

Innovations and Opportunities in European Healthcare Technologies
Post

Innovations and Opportunities in European Healthcare Technologies

In recent years, European companies have emerged as trailblazers in healthcare technology, effectively changing the face of health and patient care. Through innovation, they’re not only improving systems, processes and patient outcomes but also saving lives. These advanced European technologies are often only distributed and implemented exclusively within the European Union. The good news is...

Cardiol Rx
Post

Building an Investment Portfolio of Disruptive Healthcare Technology Companies

Overview Cardiol Therapeutics Inc. (NASDAQ: CRDL, TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company’s lead drug candidate, CardiolRx™ (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart...

Cardiol Rx
Post

Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 28th at 4:30 p.m. EDT

Overview Cardiol Therapeutics Inc. (NASDAQ: CRDL, TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company’s lead drug candidate, CardiolRx™ (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart...

Avricore Grants Options
Post

Avricore Grants Options

AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 1,625,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD $0.28 per common share. All Options were granted...